CenterBook Partners LP reduced its holdings in Amdocs Limited (NASDAQ:DOX – Free Report) by 14.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 41,759 shares of the technology company’s stock after selling 7,089 shares during the quarter. CenterBook Partners LP’s holdings in Amdocs were worth $3,555,000 at the end of the most recent reporting period.
Several other large investors have also recently bought and sold shares of the company. Jones Financial Companies Lllp bought a new stake in shares of Amdocs in the 4th quarter valued at $36,000. SBI Securities Co. Ltd. bought a new position in Amdocs during the 4th quarter worth about $41,000. Global Retirement Partners LLC increased its holdings in Amdocs by 45.6% during the 4th quarter. Global Retirement Partners LLC now owns 559 shares of the technology company’s stock worth $48,000 after purchasing an additional 175 shares in the last quarter. Private Trust Co. NA increased its holdings in Amdocs by 121.5% during the 4th quarter. Private Trust Co. NA now owns 671 shares of the technology company’s stock worth $57,000 after purchasing an additional 368 shares in the last quarter. Finally, Smartleaf Asset Management LLC increased its holdings in Amdocs by 199.6% during the 4th quarter. Smartleaf Asset Management LLC now owns 686 shares of the technology company’s stock worth $59,000 after purchasing an additional 457 shares in the last quarter. Institutional investors and hedge funds own 92.02% of the company’s stock.
Analysts Set New Price Targets
Separately, StockNews.com downgraded shares of Amdocs from a “strong-buy” rating to a “buy” rating in a research note on Friday, February 28th. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $101.20.
Amdocs Trading Up 6.0 %
Shares of NASDAQ:DOX opened at $85.32 on Thursday. The company has a 50-day simple moving average of $87.85 and a 200 day simple moving average of $87.31. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.20 and a current ratio of 1.16. The company has a market capitalization of $9.63 billion, a P/E ratio of 19.80, a price-to-earnings-growth ratio of 1.47 and a beta of 0.59. Amdocs Limited has a 52-week low of $74.41 and a 52-week high of $93.34.
Amdocs (NASDAQ:DOX – Get Free Report) last announced its earnings results on Tuesday, February 4th. The technology company reported $1.45 EPS for the quarter, missing the consensus estimate of $1.64 by ($0.19). Amdocs had a return on equity of 18.89% and a net margin of 10.19%. Sell-side analysts forecast that Amdocs Limited will post 6.21 earnings per share for the current year.
Amdocs Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Monday, March 31st will be issued a dividend of $0.527 per share. This represents a $2.11 dividend on an annualized basis and a dividend yield of 2.47%. The ex-dividend date is Monday, March 31st. This is a positive change from Amdocs’s previous quarterly dividend of $0.48. Amdocs’s payout ratio is 48.72%.
Amdocs Profile
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Featured Articles
- Five stocks we like better than Amdocs
- How to invest in marijuana stocks in 7 steps
- 3 Biopharmaceutical Stocks Bucking the Sell-Off
- Best Aerospace Stocks Investing
- Quantum Computing: The $6.5 Billion Opportunity You Can’t Ignore
- Overbought Stocks Explained: Should You Trade Them?
- Are Tariffs Threatening Disney’s Comeback Story?
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.